ISSN: 1449-2288International Journal of Biological Sciences
Global reach, higher impact
Int J Biol Sci 2021; 17(11):2770-2771. doi:10.7150/ijbs.63969 This issue Cite
Commentary
Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?
Department of Immunology and Inflammation, Imperial College London, Du Cane Road W12 0NN, London, UK.
Citation:
Santamaria S. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. Int J Biol Sci 2021; 17(11):2770-2771. doi:10.7150/ijbs.63969. https://www.ijbs.com/v17p2770.htm
Other stylesCommentary-article in Int J Biol Sci, Volume 17, 2348
Abstract
Commentary on 'Capivasertib restricts SARS-CoV-2 cellular entry: a potential clinical application for COVID-19' by Sun et al.
Keywords: SARS-CoV-2, COVID-19, PI3K/AKT pathway
Citation styles
APA
Santamaria, S. (2021). Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. International Journal of Biological Sciences, 17(11), 2770-2771. https://doi.org/10.7150/ijbs.63969.
ACS
Santamaria, S. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. Int. J. Biol. Sci. 2021, 17 (11), 2770-2771. DOI: 10.7150/ijbs.63969.
NLM
Santamaria S. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. Int J Biol Sci 2021; 17(11):2770-2771. doi:10.7150/ijbs.63969. https://www.ijbs.com/v17p2770.htm
CSE
Santamaria S. 2021. Targeting the PI3K/AKT pathway: a potential new weapon in the global fight against SARS-CoV-2?. Int J Biol Sci. 17(11):2770-2771.
This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
